Cargando…

Association and Prediction of Subclinical Atherosclerosis by Nonalcoholic Fatty Liver Disease in Asymptomatic Patients

BACKGROUND: The prevalence of nonalcoholic fatty liver disease (NAFLD) has been increasing in the general population. This study evaluated the association between NAFLD and significant coronary stenosis in asymptomatic adults and evaluated sex-based differences. METHODS: We performed a retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Ye Seul, Ko, Yeon Seo, Yun, Jae Moon, Eo, Ah Young, Kim, HaJin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735832/ https://www.ncbi.nlm.nih.gov/pubmed/33354557 http://dx.doi.org/10.1155/2020/8820445

Ejemplares similares

Nonalcoholic Fatty Liver Disease Is Associated with the Presence and Morphology of Subclinical Coronary Atherosclerosis
por: Kang, Min Kyoung, et al.
Publicado: (2015)

Nonalcoholic Fatty Liver Disease in Hispanic Youth With Dysglycemia: Risk for Subclinical Atherosclerosis?
por: Bacha, Fida, et al.
Publicado: (2017)

Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease
por: Arai, Taeang, et al.
Publicado: (2019)

Severity of nonalcoholic fatty liver disease is associated with subclinical cerebro-cardiovascular atherosclerosis risk in Korean men
por: Lee, Jung Eun, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: A systematic review and meta‐analysis
por: Zhou, Yao‐Yao, et al.
Publicado: (2018)

Low Skeletal Muscle Mass Is a Risk Factor for Subclinical Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease
por: Kang, Min-Kyu, et al.
Publicado: (2021)

Nonalcoholic fatty liver was associated with asymptomatic gallstones in a Chinese population
por: Qiao, Qiao-Hua, et al.
Publicado: (2017)

Homocysteine is not a risk factor for subclinical coronary atherosclerosis in asymptomatic individuals
por: Park, Sangwoo, et al.
Publicado: (2020)

Fatty Liver Index for Predicting Nonalcoholic Fatty Liver Disease in an Asymptomatic Korean Population
por: Cho, Eun-Ju, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis
por: Sinn, Dong Hyun, et al.
Publicado: (2016)

Novel predictors of early atherosclerosis in nonalcoholic fatty liver disease
por: Abdulaziz, Badawy Abdulkhalik, et al.
Publicado: (2023)

Marital Status and Subclinical Coronary Atherosclerosis in Asymptomatic Individuals
por: Ann, Soe Hee, et al.
Publicado: (2022)

Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old
por: Zheng, Jilin, et al.
Publicado: (2018)

Aortic flow propagation velocity, epicardial fat thickness, and osteoprotegerin level to predict subclinical atherosclerosis in patients with nonalcoholic fatty liver disease
por: Oğuz, Didem, et al.
Publicado: (2016)

Nonalcoholic fatty liver disease in long-term survivors of childhood-onset craniopharyngioma
por: Jung, So Yoon, et al.
Publicado: (2017)

Significance of Microalbuminuria in Relation to Subclinical Coronary Atherosclerosis in Asymptomatic Nonhypertensive, Nondiabetic Subjects
por: Park, Hyo Eun, et al.
Publicado: (2013)

Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency
por: Nam, Ga Eun, et al.
Publicado: (2018)

Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis
por: Xu, Xin, et al.
Publicado: (2015)

Nonalcoholic fatty liver disease as an independent risk factor for carotid atherosclerosis
por: Rasool, Abid, et al.
Publicado: (2017)

Risk of premature coronary atherosclerosis in patients with nonalcoholic fatty liver disease
por: Taylan, Gökay, et al.
Publicado: (2022)

Association between Metabolic Components and Subclinical Atherosclerosis in Korean Adults
por: Hwang, In Cheol, et al.
Publicado: (2012)

Subclinical inflammation in relation to insulin resistance in prediabetic subjects with nonalcoholic fatty liver disease
por: Hossain, Israt Ara, et al.
Publicado: (2016)

Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients
por: Liu, Lu, et al.
Publicado: (2017)

Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
por: Sao, Rahul, et al.
Publicado: (2017)

Association of Metabolic Signatures with Nonalcoholic Fatty Liver Disease in Pediatric Population
por: Chae, Woori, et al.
Publicado: (2022)

Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
por: Kim, Tae Hyung, et al.
Publicado: (2021)

SAT-LB015 Association of Subclinical Hypothyroidism with Nonalcoholic Fatty Liver in Children with Overweight and Obesity
por: Nichols, Presley, et al.
Publicado: (2019)

Screening for subclinical atherosclerosis by noninvasive methods in asymptomatic patients with risk factors
por: Castellon, Xavier, et al.
Publicado: (2013)

Relationship between lipoprotein (a) and subclinical carotid atherosclerosis in asymptomatic individuals
por: França, Victor, et al.
Publicado: (2022)

Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
por: Lei, Fang, et al.
Publicado: (2023)

The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE(−/−)FXR(−/−) Mice
por: Lee, Yenna, et al.
Publicado: (2021)

The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease
por: Seo, Ji-Yeon, et al.
Publicado: (2021)

Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
por: Arai, Taeang, et al.
Publicado: (2021)

Is subclinical atherosclerosis associated with visceral fat and fatty liver in adolescents with type 1 diabetes?
por: Atwa, Hoda, et al.
Publicado: (2018)

The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study
por: Lee, Jung-Min, et al.
Publicado: (2020)

Cholic Acid Enhances Visceral Adiposity, Atherosclerosis and Nonalcoholic Fatty Liver Disease in Microminipigs
por: Yamada, Sohsuke, et al.
Publicado: (2017)

Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis
por: Bonci, Enea, et al.
Publicado: (2015)

Subclinical thyroid dysfunction and risk of carotid atherosclerosis
por: Kim, Hosu, et al.
Publicado: (2017)

Detection of Subclinical Atherosclerosis in Asymptomatic Subjects Using Ultrasound Radiofrequency-Tracking Technology
por: Niu, Lili, et al.
Publicado: (2014)

Risk factors in nonalcoholic fatty liver disease
por: Ko, Eunji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n7612bnshhvqsllr65gjfjo4sb